InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Holmer Alan F. Officer active across 1 company, notably Corbus Pharmaceuticals Holdings, Inc.. In total, 4 reports have been recorded. History available since 26 January 2024. The latest transaction was disclosed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
HOLMER ALAN F is a declarant linked to Corbus Pharmaceuticals Holdings, Inc., where he is a Director. The record shows 4 filings in total, and across the 4 sampled recent filings, the period runs from 2024-01-30 to 2025-06-02, with the modal transaction nature listed as Attribution.